Back

Beverley Moore

Partner

Ottawa
BMoore@blg.com
613.369.4784

Expertise

Amy Courdin

Practice Assistant

Ottawa
acourdin@blg.com
613.787.3558
613.237.0234
Beverley is national leader of BLG's Intellectual Property Litigation Group. She practises in all areas of intellectual property litigation, with a focus on complex patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations.

Beverley also advises clients on patent portfolio management, including how to navigate IP regulatory issues such as listing patents on the Patent Register, and reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection, and the Register of Innovative Drugs as it relates to data protection. In addition, Beverley advises on patentability, validity, and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada.

Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients.

Beverley consulted on the implementation and application of the intellectual property provisions of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and has also advised on the United States-Mexico-Canada Agreement (USMCA).

Beverley has advocated before the Federal Court and Federal Court of Appeal, as well as the Patented Medicine Prices Review Board. Beverley is one of the co-vice chairs of IPO's Pharmaceutical and Biotechnology Committee and chairs that group's Drug Pricing Subcommittee. Beverley also serves on the BLG's Thought Leadership Committee and mentors several of the firm's students and associates.

Experience

  • Counsel for innovative companies asserting validity and infringement of patents during proceedings brought pursuant to the NOC Regulations.
  • Counsel for innovative companies challenging and judicially reviewing the Minister of Health’s refusal to list patents on the Patent Register.
  • Counsel for innovative companies defending generic companies’ claims for damages pursuant to s. 8 of the NOC Regulations.
  • Counsel for innovative companies in patent infringement and validity proceedings involving claims to compounds, formulations and uses of drugs and the processes to make them.
  • Advising clients on patent portfolio issues relating to data protection, listing patents on the Patent Register and reporting to the Patented Medicines Prices Review Board.
  • Preparing freedom-to-operate, infringement and validity opinions with respect to intellectual property matters.
  • Counsel for clients seeking leave to intervene and intervening in proceedings before the Supreme Court of Canada.
  • Counsel for clients seeking leave to intervene and intervening in proceedings before the Patented Medicines Prices Review Board.

Beyond Our Walls

Professional Involvement

  • Vice Co-Chair, Intellectual Property Owners Association (IPO), Pharmaceutical & Biotechnology Issues Committee
  • Member, Intellectual Property Institute of Canada (IPIC), IPIC Editorial Board for the Canadian Intellectual Property Review, IPIC Competition Law
  • Director, “Understanding Patents” course as part of the IPIC/McGill Summer Courses in Intellectual Property, 2020-2021
  • Assistant Director, “Understanding Patents” course as part of the IPIC/McGill Summer Courses in Intellectual Property, 2018-2020
  • Member, Canadian Bar Association (CBA), Court Practice Committee
  • Member, Advocate’s Society
  • Member, County of Carleton Law Association
  • Member, BIOTECanada’s Health Advisory Board and Subsequent Entry Biologics Task Force
  • Member, Chiefs in Intellectual Property (ChIPs)

Awards & Recognitions

  • Selected by peers for inclusion in the 2021 edition of Canadian Legal Lexpert Directory® (Biotechnology [since 2019]; Intellectual Property Law [since 2019]; and Litigation – Intellectual Property [since 2020]).
  • Recognized in the 2021 edition of Lexpert Special Edition: Health Sciences.
  • Recognized in the 2021 edition of Lexpert Special Edition: Technology.
  • Recognized in the 2022 edition (and since 2019) of The Best Lawyers in Canada® (Intellectual Property Law) and in 2020 (Biotechnology).
  • Recognized in the 2020/21 edition of Managing Intellectual Property’s IP Stars (Patent).

Bar Admission & Education

  • Ontario, 2003
  • LLB, Queen's University, 2002
  • MSc, Biochemistry, Queen's University, 2000
  • BSc (Hons.), Biochemistry, Queen's University, 1997

This website uses cookies

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings, please view our cookie policy. By continuing to use this site without changing your settings, you consent to our use of cookies in accordance with our cookie policy.

Accept